Legend Biotech Corporation
LEGNNASDAQHealthcare● Active
$31.02
$-1.61(-4.92%)
Market Cap$5.7B
P/E Ratio—
52W High$45.297
52W Low$16.24
Legend Biotech Corporation（LEGN）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LEGN · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.03B | $0.63B | $0.29B | $0.12B | $0.07B |
| Cost of Revenue | $0.41B | $0.23B | $0.14B | $0.07B | $0.00B |
| Gross Profit | $0.62B | $0.39B | $0.14B | $0.05B | $0.07B |
| Gross Margin %(computed) | 60.34% | 62.60% | 49.42% | 44.14% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.41B | $0.41B | $0.38B | $0.34B | $0.31B |
| G&A Expenses | $0.14B | $0.14B | $0.11B | $0.08B | $0.05B |
| Total Operating Expenses | $0.76B | $0.70B | $0.58B | $0.51B | $0.46B |
| Operating Income | ($0.14B) | ($0.30B) | ($0.44B) | ($0.46B) | ($0.39B) |
| Operating Margin %(computed) | -13.27% | -48.35% | -154.13% | -389.40% | -569.97% |
| Interest Income | $0.04B | $0.06B | $0.05B | $0.01B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.01B | $0.00B |
| Income Before Tax | ($0.28B) | ($0.16B) | ($0.52B) | ($0.45B) | ($0.41B) |
| Income Tax Expense | $0.01B | $0.02B | ($0.00B) | $0.00B | ($0.00B) |
| Net Income | ($0.30B) | ($0.18B) | ($0.52B) | ($0.45B) | ($0.40B) |
| Net Margin %(computed) | -28.85% | -28.22% | -181.75% | -381.48% | -586.38% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.60 | $-0.97 | $-2.94 | $-2.81 | $-2.74 |
| Wtd Avg Shares | 0.18B | 0.18B | 0.18B | 0.16B | 0.14B |
| EBITDA | ($0.23B) | ($0.11B) | ($0.48B) | ($0.42B) | ($0.39B) |
| EBITDA Margin %(computed) | -22.58% | -18.04% | -167.59% | -356.00% | -570.10% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Legend Biotech Corporation
关于Legend Biotech Corporation（LEGN）损益表
Legend Biotech Corporation（LEGN）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LEGN实现营收$1.03B，毛利润$0.62B（毛利率60.34%），净利润($0.30B)（净利率-28.85%）。
常见问题
LEGN · 4 问Legend Biotech Corporation（LEGN）2025财年营收为$1.03B，同比up64.0%。
LEGN revenueLEGN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08